The popularity of using natural remedies to treat illness and disease is not only becoming more prevalent but more practical, as well.

The effects of Curcumin on prostate cancer and dementia shows promise as a treatment.

The lack of side effects and accessibility of natural treatments make them attractive to those who have little or no insurance and those who are extremely sensitive to pharmaceuticals.

The researchers found that curcumin blocked two genetic receptors necessary for prostate cancer advancement. These receptors have been shown is past studies to predict cancer incidence and rate of growth of existing tumors. They noted that the spice extract was “a potent inhibitor of both cell cycle and survival in prostate cancer cells.”

In a separate research body, scientists found that curcumin prolongs life and enhances activity of brain neurons, acting as a neuroprotective shield against Alzheimer’s disease advancement. The research team determined that curcumin acted to prevent the damaging accumulation of amyloid fibrils around the nerve synapse. Amyloid tangles are known to prevent normal electrical and chemical transmissions required to form memories and maintain cognition.

It is estimated that 30-40 percent of men over 50 years old will be affected by prostate cancer, however, there is some debate in the medical community regarding which course of action is best going forward.

Routine monitoring of PSA (Prostate Specific Antigen) may reveal false- positive, and positive results which may later lead to unnecessary and often harmful treatment.

Elevated levels of this protein can indicate prostate cancer, but it can be caused by other things as well..

Several studies have suggested many men are over-screened for prostate cancer, and this over-screening has in many cases caused more harm than good, leading men to chose a biopsy and treatment for a slow-growing cancer that may have never caused them harm during their lifetimes.

Alternative strategies for men with low-risk prostate cancer typically fall into two camps: observation with and without the intent to cure.

Do get a second opinion when treating your condition and consult your physician for the best course of action for your case.

Meat and dairy products have been getting a bad rap from cardiologists with links to heart disease and now new studies find that well done red meat is linked to greater risk of prostate cancer.

When meat is cooked—and charred—at high temperatures over an open flame, a reaction occurs that causes the formation of two chemicals: heterocyclic amines (HCAs) and polycyclic aromatic hydrocarbons (PAHs). In animal studies, these chemicals have been shown to cause several types of cancer, including prostate cancer.

Although by now it is well established that red meat increases the risk of heart disease and colorectal cancer, its role in prostate cancer has been less clear. Numerous studies have investigated a possible link between meat consumption and prostate-cancer risk, but the results have been inconsistent.

Men who receive a diagnosis of prostate cancer are faced with a frightening array of options.

To live with cancer might seem to be unthinkable, however, in light of the alternatives a slow growing cancer may be easier to live with than the side effects of cancer treatment and in the worse case, death from infection and other surgical complications.

Many men who agree to a PSA test do not understand what it is. Some common misconceptions:

— It shows cancer. In fact, PSA is just a measure of inflammation, and it can be elevated for many reasons besides cancer: normal enlargement of the prostate with age, an infection, even recent sex, a strenuous bike ride or horseback riding.

— It’s been proven to save lives. Only two large, well-done studies have looked at this, the task force says. The American study found annual screening did not lower the chances of dying of prostate cancer. However, cancer fear is so great, and belief in the value of screening so ingrained, that half the men assigned to the group not offered PSA tests got one anyway. That made comparisons to the group given annual screening difficult. For that reason, some doctors don’t believe the study’s conclusion.
The other study, conducted in Europe, found a small benefit for certain age groups screened every two to seven years — not annually. However, one Swedish center had such rosy results that scientists think it may have biased the whole study. If that center is excluded, no benefit from the PSA test is seen.

— The task force’s stance goes against past advice. Routine PSA testing has been supported by some advocacy groups and by urologists, the doctors who do the tests and treatments. But it has not been pushed by major scientific groups, the American Cancer Society or the government.

— It finds cancer early so you’re more likely to survive. About 90 percent of prostate cancers found through screening are early-stage. Most will grow so slowly they will never threaten a man’s life, but there’s no good way to tell which ones will. Research suggests that tumors causing symptoms are more likely to warrant treatment than those that are not. Also, finding aggressive prostate tumors early may not affect how lethal they prove to be; the PSA test may just let men learn of them sooner than they otherwise would.

Men are not getting the whole truth when it comes to sex after prostate cancer.

The reality for many of the 240,000 men in the United States in whom prostate cancer is diagnosed each year is not all that rosy, at least when it comes to their intimate lives. After surgery and radiation treatments, many men quickly discover that sex will never be normal again. Sensations change. Many men can no longer achieve erections without pumps or pills. For some, the ability to have sex goes away entirely.